Study details
Enrolling now
tPBM in Older Adults With Traumatic Brain Injury
NYU Langone Health
NCT IDNCT06956404ClinicalTrials.gov data as of Apr 2026
Target enrollment
70
Study length
about 3.2 years
Ages
55–85
Locations
1 site in NY
About this study
Researchers are testing a device called transcranial photobiomodulator (tPBM) to see if it helps older adults with traumatic brain injury. The trial will examine how tPBM affects blood flow and executive function.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Transcranial photobiomodulator (tPBM)
- 2.Use Transcranial photobiomodulator (tPBM) in sham mode
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low8%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Change in number of treatment emergent adverse events as measured by the Systematic Assessment for Treatment Emergent Effects-Systematic Inquiry (SAFTEE-SI)
Devices
therapeutic